Clinical studies show that some individuals feel less hungry just a few days after their initial dose, although the full appetite-suppressing effects may develop gradually over several weeks as the medication builds up in your system
However, evidence remains preliminary, and their long-term efficacy and safety, particularly in combination with GLP-1 therapies, have yet to be established
GI effects nausea, diarrhea, vomiting, constipation are the most-reported side effects
Semaglutide is available as pre-filled injection pens (Ozempic and Wegovy) and oral tablets (Rybelsus), each with distinct packaging
PlexusDx's Precision Peptide Genetic Test identifies variations in the GLP1R gene (rs6923761) that influence how efficiently your body's natural GLP-1 signals reach your brain, revealing whether your genetic blueprint naturally produces robust appetite control or requires external support
Double blind, randomized, placebo or semaglutide